As a result, HIF1α may promote miR-183/96/182 cluster expression, out of which miR-183 can also target VHL mRNAs to further inhibit its expression and constitutively promote HIF1α expression and associated cancer progression in a feedback loop mechanism. The gene discussed is HIF1A; the disease is cancer.